Risk-Benefits of Oxcarbazepine vs Carbamazepine

J Gordon Millichap

doi:10.15844/pedneurbriefs-18-10-7

Risk-Benefits of Oxcarbazepine vs Carbamazepine

Pediatric Neurology Briefs

Volume 18 (2004): Issue 10

By: J Gordon Millichap

Open Access

|Oct 2004

Abstract

The clinical differences between oxcarbazepine (OXC) and carbamazepine (CBZ) are reviewed in terms of efficacy, tolerability, and interaction with other drugs in a study at Universitat Bonn, Berlin, Germany.

References

Schmidt D Elger CE What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav 2004 Oct 5 5 627 35 10.1016/j.yebeh.2004.07.004 15380112
Open DOI Search in Google Scholar Back to article
Vazquez B Monotherapy in epilepsy: role of the newer antiepileptic drugs Arch Neurol 2004 Sep 61 9 1361 5 10.1001/archneur.61.9.1361 15364680
Open DOI Search in Google Scholar Back to article
Gelisse P Genton P Kuate C Pesenti A Baldy-Moulinier M Crespel A Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies Epilepsia 2004 Oct 45 10 1282 6 10.1111/j.0013-9580.2004.19704.x 15461683
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-18-10-7 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 78 - 79

Published on: Oct 1, 2004

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Oxcarbazepine,

Carbamazepine,

Monohydroxy Derivative

© 2004 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 18 (2004): Issue 10